Trademark Search in Canada

VELABS

View On IC.GC.CA

REGISTERED

on 19 Jul 2021

Last Applicant/ Owned by

EUROPEAN MOLECULAR BIOLOGY LABORATORY

Meyerhofstr. 169012 Heidelberg

Serial Number

1894921 filed on 20^th Apr 2018

Registration Number

TMA1104012 registered on 19^th Jul 2021

Registration expiry Date

19^th Jul 2031

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

K1P5Y6

VELABS

Trademark usage description

antibodies for medical use, namely, for diagnostic testing and therapeutic intervention; immunoglobulins for medical use, namely, for agonizing and an Read More

Classification Information

Class [005]
Antibodies for medical use, namely, for diagnostic testing and therapeutic intervention; immunoglobulins for medical use, namely, for agonizing and antagonizing of signaling activities of membrane bound signal proteins and receptors; vaccines for human use; scaffold-proteins for medical use, namely, for the stabilization and modulation of kinetic activities of membrane bound signal proteins and receptors; cell-based assays for medical use, namely, for screening and testing of body fluids and cells therein; veterinary preparations, namely, for the treatment of infectious diseases, namely, influenza, hepatitis C, SARS-CoV-2, respiratory and genital infections, ear and eye infections, topical infections, swine dysentery, bacterial enteritis, Bluecomb, pneumonia and metabolic diseases, namely, obesity, NASH, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; medical preparations for the treatment of cancerous diseases, infectious diseases, namely, influenza, hepatitis C, SARS-CoV-2, respiratory and genital infections, ear and eye infections, topical infections, swine dysentery, bacterial enteritis, Bluecomb, pneumonia and metabolic diseases, namely, obesity, NASH, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia and for the prevention and treatment of allergies; pharmaceuticals for the treatment of infectious diseases, namely, influenza, hepatitis C, SARS-CoV-2, respiratory and genital infections, ear and eye infections, topical infections, swine dysentery, bacterial enteritis, Bluecomb, pneumonia, for use in oncology, and for the treatment of metabolic diseases, namely, obesity, NASH, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia

Classification kind code

Class [009]
Scientific, optical, measuring apparatus and instruments, namely, optical mirrors, lasers not for medical use, namely, ultrashort pulse lasers for spectroscopy and quantitative fluorescence analysis; data processing equipment, namely, computer hardware for analyzing, sorting, comparing and high throughput analysis of fluorescent signals and nucleotide expression levels; computer software for database management, for measuring of droplet particle flow rates and fluorescence, for sorting and filtering of droplet particles according to filter rules, for data visualization in the format of 2D and 3D charts, graphs and videos, and for use as a spreadsheet; laboratory equipment, namely, microfluidic chips and laboratory swabs

Classification kind code

Class [042]
Scientific and technological services, namely, scientific testing and screening of cell and molecule reservoirs against target proteins in the fields of pharmaceuticals and biochemicals and new product research and design relating thereto; industrial analysis and research services in the fields of pharmaceuticals and biochemicals; design and development of computer hardware and software; scientific research services, namely the development of assays and cell models for use in high throughput screening for clinical and laboratory use; drug discovery services, namely, research and development of new drugs; antibody screening services for scientific research purposes; vaccine screening services for scientific research purposes

Classification kind code

Class [044]
Medical services in the field of preclinical antibody screening and personalized screening of small molecules, peptides and human immune repertoires against individual tissue derived cells; medical diagnostic services and screening services; medical screening of patient-derived antibodies; medical services in the field or personalized medicine, namely identifying risk factors of disease, prognostic testing, gene testing, identifying physiological characteristics, monitoring patient progress and efficacy of patient therapies and personalized cancer therapies

Classification kind code

Mark Details

Serial Number

1894921

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 19^th May 2021	Registration Pending
Submitted for opposition 42 on 24^th Feb 2021	Advertised
Submitted for opposition 26 on 1^st Feb 2021	Approved
Submitted for opposition 27 on 1^st Feb 2021	Approval Notice Sent
Submitted for opposition 15 on 26^th Jun 2020	Correspondence Created
Submitted for opposition 22 on 15^th Oct 2019	Search Recorded
Submitted for opposition 20 on 15^th Oct 2019	Examiner's First Report
Submitted for opposition 31 on 25^th Apr 2018	Formalized
Submitted for opposition 1 on 23^rd Apr 2018	Created
Submitted for opposition 30 on 20^th Apr 2018	Filed